Washington
Q3 2026Lobbying Q3 None no reports
YoY n/a vs Q3 2025
Members 0 all time
Buys / sells 0 / 0 0 trades
BICX
BioCorRx Inc.$0.2110 +0.00 (+0.00%)
Oct 23 4:00 PM ET · prev $0.2110
Next earnings
Nov 12
in 17 days
1 year
−47.3%
from $0.4000 · Oct 27
30 days
+5.0%
from $0.2010
52-week range
$0.1520–0.4950
−57% from high · low Aug 14
Avg volume 20D
730
Oct 12 spike 6.2K
Short interest
🔒 Subscribers only
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · 90 days
Balance 0 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 12, 2026
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- X Jul 31 Short interest falls 68.8% to 543
- X Sep 15 Short interest falls 44.3% to 10.1K
Signal stack
Where each data set points today.
- TrendRANGE
7% below its 50-day average.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 4, 2026 SEC
Director Kate Beebe DeVarney, Ph.D. resigned from the BioCorRx board effective August 31, 2026. The filing explicitly…
8-K — Impact 2/10
Aug 12, 2026 Earnings calendar
BICX Q2 2026 Earnings Scheduled — 2026-08-12
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Recent
Earnings setup
EstimatesNov 12
reports in 17 days
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 neutralAll BICX filing & press-release reports (1)
- 8-K reportSep 4, 2026